Frankly Speaking About Family Medicine

Pri-Med

A weekly Podcast series covering newsworthy topics in primary care medicine. Thoughts? Suggestions? Email us at FranklySpeaking@pri-med.com

About PodLP

PodLP is the leading podcast app for feature phones. With 10M+ installs in nearly every country, PodLP is available for KaiOS on the KaiStore and JioStore, as well as Cloud Phone and Android. If you're interested in promoting "Frankly Speaking About Family Medicine" on PodLP, contact sales@podlp.com.

Screenshots are mockup renders of PodLP for KaiOS. Actual design may vary based on platform, operating system, and app version.

Frankly Speaking About Family Medicine

Episodes (487)

Mar 30th GLP-1 RAs and Hair Loss—Evaluating and Managing a Potential Side Effect - Frankly Speaking Ep 478
Mar 23rd AI Scribing in Practice: Balancing Patient Considerations and Clinician Wellbeing - Frankly Speaking Ep 477
Mar 16th Melatonin: Is a “Natural” Sleep Aid as Harmless as We Think? - Frankly Speaking Ep 476

Frankly Speaking About Family Medicine

Mar 30, 2026
10½ minutes
9 MB

Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-478 Overview: As glucagon-like peptide-1 receptor agonists (GLP-1 RAs) become increasingly common in managing obesity, it is important for clinicians to recognize lesser-known adverse effects. This episode highlights the potential link between GLP-1 RAs and alopecia, equipping you to better evaluate, counsel, and manage patients reporting hair loss. Episode resource links: Alsuwailem OA, Alanazi R, Almutairi HM, Asiree RH, Almutairi W, Almutairi TM, Zamandar A, Alkhames S. Hair Loss Associated With Glucagon-Like Peptide-1 (GLP-1) Receptor Ago...

Frankly Speaking About Family Medicine

GLP-1 RAs and Hair Loss—Evaluating and Managing a Potential Side Effect - Frankly Speaking Ep 478

Pri-Med

00:00 -09:32